纯合子β地中海贫血长期螯合疗法的对照试验。 - Suppr | 超能文献

A controlled trial of long-term chelation therapy in homozygous beta-thalassemia.

作者信息

Letsky E A

出版信息

Birth Defects Orig Artic Ser. 1976;12(8):31-41.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A controlled trial of long-term chelation therapy in homozygous beta-thalassemia.纯合子β地中海贫血长期螯合疗法的对照试验。

Birth Defects Orig Artic Ser. 1976;12(8):31-41.

2

Management of thalassemia in Los Angeles.洛杉矶地中海贫血的管理

Birth Defects Orig Artic Ser. 1976;12(8):43-52.

3

Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia.纯合子β地中海贫血患者的螯合疗法与铁蛋白水平

Prog Clin Biol Res. 1979;34:351-9.

4

The effect of treatment with long-term chelating agents on iron overload in thalassaemia.长期使用螯合剂治疗对地中海贫血铁过载的影响。

Br J Haematol. 1973 Aug;25(2):285.

5

Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.地中海贫血中的铁过载：磁共振成像、血清铁蛋白与肝脏铁含量的对比分析

Haematologica. 1995 Sep-Oct;80(5):398-404.

6

Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.β地中海贫血的螯合疗法：去铁胺的益处与局限性

Semin Hematol. 1995 Oct;32(4):304-12.

7

Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid.

Exp Hematol. 1979 Feb;7(2):74-80.

8

[Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].

Pediatria (Napoli). 1981 Sep 30;89(3):479-92.

9

Measurement of iron status.铁状态的测量。

Prog Clin Biol Res. 1989;309:85-92.

10

Prog Clin Biol Res. 1983;127:33-42.

引用本文的文献

1

Early iron overload in beta-thalassaemia major: when to start chelation therapy?重型β地中海贫血的早期铁过载：何时开始螯合治疗？

Arch Dis Child. 1982 Dec;57(12):929-33. doi: 10.1136/adc.57.12.929.

2

Survival and desferrioxamine in thalassaemia major.重型地中海贫血的生存与去铁胺治疗

Br Med J (Clin Res Ed). 1982 Apr 10;284(6322):1081-4. doi: 10.1136/bmj.284.6322.1081.